Search Results - "Pamplona" :: UTM Library Massive Scholar Tracking

4841

Advanced Parkinson's disease: Clinical characteristics and treatment. Part II by J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, Á. Sesar, F. Valldeoriola-Serra, R. Yañez

Published 2013-11-01

Get full text

Article

4842

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in... by Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C

Published 2016-12-01

“…Santiago Grau,1 Jose Ramon Azanza,2 Isabel Ruiz,3 Carlos Vallejo,4 Josep Mensa,5 Johan Maertens,6 Werner J Heinz,7 Jon Andoni Barrueta,8 Carmen Peral,9 Francisco Jesús Mesa,8 Miguel Barrado,10 Claudie Charbonneau,11 Darío Rubio-Rodríguez,12 Carlos Rubio-Terrés12 1Pharmacy Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, 2Clinical Pharmacology Department, Clínica Universidad de Navarra, Pamplona, 3Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona, 4Hematology Department, Hospital Universitario Donostia, San Sebastián, 5Infectious Diseases Department, Hospital Clínic de Barcelona, Barcelona, Spain; 6Hematology Department, University Hospital Gasthuisberg, Leuven, Belgium; 7Hematology/Oncology Department, Medizinische Klinik und Poliklinik II, Universitätsklinikum, Würzburg, Germany; 8Medical Department, 9Economics and Outcomes Research Department, Pfizer S.L.U, Alcobendas, 10Clinical Trials Department, Trial Form Support, Madrid, Spain; 11Pharmacoeconomics Department, Pfizer International Operations, Paris, France; 12Pharmacoeconomics Department, Health Value, Madrid, Spain Objective: According to a recent randomized, double-blind clinical trial comparing the combination of voriconazole and anidulafungin (VOR+ANI) with VOR monotherapy for invasive aspergillosis (IA) in patients with hematologic disease or with hematopoietic stem cell transplant, mortality was lower after 6 weeks with VOR+ANI than with VOR monotherapy in a post hoc analysis of patients with galactomannan-based IA. …”

Get full text

Article

4843

Intestinal Lipid Metabolism Genes Regulated by miRNAs by María Belén Ruiz-Roso, Judit Gil-Zamorano, María Carmen López de las Hazas, Joao Tomé-Carneiro, María Carmen Crespo, María Jesús Latasa, Olivier Briand, Daniel Sánchez-López, Ana I. Ortiz, Francesco Visioli, Francesco Visioli, J. Alfredo Martínez, J. Alfredo Martínez, J. Alfredo Martínez, Alberto Dávalos

Published 2020-07-01

Get full text

Article

4844

0.6-V 1.65-μW Second-Order <i>G<sub>m</sub>-C</i> Bandpass Filter for Multi-Frequency Bioimpedance Analysis Based on a Bootstrapped Bulk-Driven Voltage Buffer by Juan M. Carrillo, Carlos A. de la Cruz-Blas

Published 2022-11-01

Get full text

Article

4845

Interactional Effects of Climate Change Factors on the Water Status, Photosynthetic Rate, and Metabolic Regulation in Peach by Sergio Jiménez, Sergio Jiménez, Masoud Fattahi, Masoud Fattahi, Khaoula Bedis, Shirin Nasrolahpour-moghadam, Shirin Nasrolahpour-moghadam, Juan José Irigoyen, Yolanda Gogorcena

Published 2020-02-01

Get full text

Article

4846

Metasurface-Inspired Flexible Wearable MIMO Antenna Array for Wireless Body Area Network Applications and Biomedical Telemetry Devices by Ayman A. Althuwayb, Mohammad Alibakhshikenari, Bal S. Virdee, Nasr Rashid, Khaled Kaaniche, Ahmed Ben Atitallah, Ammar Armghan, Osama I. Elhamrawy, Chan Hwang See, Francisco Falcone

Published 2023-01-01

Get full text

Article

4847

Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck by Anagha Gogate, Bryan Bennett, Zia Poonja, Grant Stewart, Ana Medina Colmenero, Petr Szturz, Courtney Carrington, Clara Castro, Eric Gemmen, Ashley Lau, Alberto Carral Maseda, Eric Winquist, Virginia Arrazubi, Desiree Hao, Audrey Cook, Joaquina Martinez Galan, Lisardo Ugidos, David Fernández Garay, David Gutierrez Abad, Robert Metcalf

Published 2023-07-01

Get full text

Article

4848

Clinical and Demographic Characteristics of Centenarians versus Other Age Groups Over 75 Years with Hip Fractures by Bermejo Boixareu C, Ojeda-Thies C, Guijarro Valtueña A, Cedeño Veloz BA, Gonzalo Lázaro M, Navarro Castellanos L, Queipo Matas R, Gómez Campelo P, Royuela Vicente A, González-Montalvo JI, Sáez-López P

Published 2023-03-01

“…Cristina Bermejo Boixareu,1,&ast; Cristina Ojeda-Thies,2,&ast; Ainhoa Guijarro Valtueña,3 Bernardo Abel Cedeño Veloz,4 María Gonzalo Lázaro,4 Laura Navarro Castellanos,5 Rocío Queipo Matas,5,6 Paloma Gómez Campelo,5 Ana Royuela Vicente,7 Juan Ignacio González-Montalvo,5,8 Pilar Sáez-López5,9,10 1Geriatrics Department, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain; 2Orthopaedic Surgery and Traumatology Department, 12 de Octubre University Hospital, Madrid, Spain; 3Orthopaedic Surgery and Traumatology, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain; 4Geriatrics Department, University Hospital of Navarra, Pamplona, Spain; 5La Paz Institute for Health Research - IdiPAZ, Hospital Universitario La Paz - Universidad Autónoma de Madrid, Madrid, Spain; 6European University of Madrid, Madrid, Spain; 7Biostatistics Unit, Puerta de Hierro Majadahonda University Hospital, IDIPHISA, CIBERESP, Madrid, Spain; 8Geriatrics Department, La Paz University Hospital, Madrid, Spain; 9Geriatrics Department, Fundación Alcorcón University Hospital, Madrid, Spain; 10Spanish National Hip Fracture Registry, Madrid, Spain&ast;These authors contributed equally to this workCorrespondence: Cristina Bermejo Boixareu, Geriatrics Department, Puerta de Hierro University Hospital, Madrid, Spain, Email cristina_bermejo@hotmail.comObjective: The primary objective was to describe the clinical characteristics, management, and outcomes of centenarians with fragility hip fracture and compare them to other age groups. …”

Get full text

Article

4849